Product Images Allopax

Front Carton Label: The NDC (National Drug Code) number for the AlleePAX medication is 69817-0201-1. It is intended for prescription use only and should be stored at room temperature, protected from light and out of reach of children. The LOT number is 12345678, and the container should be tightly closed. It is for external use only, and contact with eyes should be avoided. It should be prepared as instructed before dispensing. Marketed by PharmaGenetico LLC, AlleePAX is a pharmacy drug in San Antonio, TX 78257. Back Carton Label: The back carton label declares the same NDC number and is intended for prescription use only. The FDA (Food and Drug Administration) has not approved Allo*PAX to cure, treat, or mitigate disease. Allo*PAX is intended for preparation following state and federal regulations and is available only by prescription. Each pack contains Levocetirizine Dihydrochloride and Loratadine USP, and it is only available for use upon prescription. It is labeled Rx Only and has a weight of 60g when dispensed.*

The AlloePAX pack contains pre-weighed Levocetirizine dihydrochloride, Loratadine, and PCCA Lipoderm® base cream. The pharmacist must empty the PCCA Lipoderm® base into an appropriate mixing container and then combine the Loratadine powder with the PCCA Lipoderm® base. The mixture should be stirred gently for about 1-2 minutes until it appears homogeneous. Next, the Levocetirizine dihydrochloride powder should be combined with the PCCA Lipoderm® base/Loratadine mixture and stirred gently for about 1-2 minutes until it appears homogeneous. The formulation should be stored at controlled room temperature and discarded after 30 days of being dispensed. The product should only be used externally and kept out of reach of children. The pharmacy is responsible for properly labeling the finished product according to state and federal guidelines. The active ingredients include Levocetirizine dihydrochloride and Loratadine with the inactive ingredient being PCCA Lipoderm®.*